Roy A Whitfield insider trades
Open-market stock purchases and sales by Roy A Whitfield, Unknown at Nektar Therapeutics, from SEC Form 4 filings since Jan 25, 2010.
Track record: 25% of 4 scored buys are up 5% or more since purchase, averaging +4%.
Open-market stock purchases and sales by Roy A Whitfield, Unknown at Nektar Therapeutics, from SEC Form 4 filings since Jan 25, 2010.
Track record: 25% of 4 scored buys are up 5% or more since purchase, averaging +4%.